Mato Santos, Susana

Targeting the Endocannabinoid System in Adult Fragile X Mice

FRAXA Research Foundation 2013 Grants • 2014 Grants • Completed Research Grants • Drug Repurposing • Mato Santos, Susana • Ozaita, Andres • Treatment Targets • University Pompeu Fabra September 15, 2014May 17, 2020CBD, endocannabinoid, rimonabant

With a $90,000 grant from the FRAXA Research Foundation from 2013-2014, Dr. Andres Ozaita led a team to test rimonabant’s ability to blockade the CB1 receptor. Blocking CB1 has shown potential to reverse most symptoms of disease in mice bred to mimic Fragile X syndrome.